Cargando…
Fat embolism syndrome with neurological involvement: A case report
BACKGROUND: Fat Embolism Syndrome (FES) occurs when the contents (or some component of) the bone marrow is released into the circulation, generally as the result of long bone fracture. It poses significant challenges in both diagnosis and treatment and, as such, is primarily a diagnosis of exclusion...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804199/ https://www.ncbi.nlm.nih.gov/pubmed/35128021 http://dx.doi.org/10.1016/j.tcr.2022.100607 |
_version_ | 1784643022375354368 |
---|---|
author | Ostlie, Andrew Gilbert, Megan Lewis, Carey Ostlie, Daniel Hargis-Villanueva, Angela |
author_facet | Ostlie, Andrew Gilbert, Megan Lewis, Carey Ostlie, Daniel Hargis-Villanueva, Angela |
author_sort | Ostlie, Andrew |
collection | PubMed |
description | BACKGROUND: Fat Embolism Syndrome (FES) occurs when the contents (or some component of) the bone marrow is released into the circulation, generally as the result of long bone fracture. It poses significant challenges in both diagnosis and treatment and, as such, is primarily a diagnosis of exclusion with no definitive treatment. We present a case where heightened awareness of the clinical team allowed for early identification and immediate initiation of supportive care, nitric oxide (NO) for potential mitigation of right heart failure, and pharmacological treatment with atorvastatin. PATIENT: A 16-year-old male with multi-system trauma, including bilateral long-bone fractures, developed Fat Embolism Syndrome with neurological and respiratory symptoms within 24 h of admission. RESULTS: Within 24 h of initiation of high dose atorvastatin and inhaled Nitric Oxide our patient showed signs of improvement, including decreasing oxygen requirement's and normalization of mental status. CONCLUSION: We postulate that the combined therapy of high-dose atorvastatin with Nitric Oxide may have played a role in our patients' full recovery in a shortened timeframe. Ideally, further prospective research is needed to determine a universally accepted treatment regimen for pediatric patients with FES. |
format | Online Article Text |
id | pubmed-8804199 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88041992022-02-04 Fat embolism syndrome with neurological involvement: A case report Ostlie, Andrew Gilbert, Megan Lewis, Carey Ostlie, Daniel Hargis-Villanueva, Angela Trauma Case Rep Case Report BACKGROUND: Fat Embolism Syndrome (FES) occurs when the contents (or some component of) the bone marrow is released into the circulation, generally as the result of long bone fracture. It poses significant challenges in both diagnosis and treatment and, as such, is primarily a diagnosis of exclusion with no definitive treatment. We present a case where heightened awareness of the clinical team allowed for early identification and immediate initiation of supportive care, nitric oxide (NO) for potential mitigation of right heart failure, and pharmacological treatment with atorvastatin. PATIENT: A 16-year-old male with multi-system trauma, including bilateral long-bone fractures, developed Fat Embolism Syndrome with neurological and respiratory symptoms within 24 h of admission. RESULTS: Within 24 h of initiation of high dose atorvastatin and inhaled Nitric Oxide our patient showed signs of improvement, including decreasing oxygen requirement's and normalization of mental status. CONCLUSION: We postulate that the combined therapy of high-dose atorvastatin with Nitric Oxide may have played a role in our patients' full recovery in a shortened timeframe. Ideally, further prospective research is needed to determine a universally accepted treatment regimen for pediatric patients with FES. Elsevier 2022-01-26 /pmc/articles/PMC8804199/ /pubmed/35128021 http://dx.doi.org/10.1016/j.tcr.2022.100607 Text en © 2022 Published by Elsevier Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Ostlie, Andrew Gilbert, Megan Lewis, Carey Ostlie, Daniel Hargis-Villanueva, Angela Fat embolism syndrome with neurological involvement: A case report |
title | Fat embolism syndrome with neurological involvement: A case report |
title_full | Fat embolism syndrome with neurological involvement: A case report |
title_fullStr | Fat embolism syndrome with neurological involvement: A case report |
title_full_unstemmed | Fat embolism syndrome with neurological involvement: A case report |
title_short | Fat embolism syndrome with neurological involvement: A case report |
title_sort | fat embolism syndrome with neurological involvement: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804199/ https://www.ncbi.nlm.nih.gov/pubmed/35128021 http://dx.doi.org/10.1016/j.tcr.2022.100607 |
work_keys_str_mv | AT ostlieandrew fatembolismsyndromewithneurologicalinvolvementacasereport AT gilbertmegan fatembolismsyndromewithneurologicalinvolvementacasereport AT lewiscarey fatembolismsyndromewithneurologicalinvolvementacasereport AT ostliedaniel fatembolismsyndromewithneurologicalinvolvementacasereport AT hargisvillanuevaangela fatembolismsyndromewithneurologicalinvolvementacasereport |